Integrated Filing — IndAS

General information about company
Scrip Code	500153
NSE Symbol	GANESHBE
MSEI Symbol	NOTLISTED
ISIN	INE388A01029
Name of company	GANESH BENZOPLAST LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	07-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	14-May-2025   13:00:00
End date and time of board meeting	14-May-2025   17:25:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	999340000	3743110000
	Other income	50520000	176930000
	Total income	1049860000	3920040000
2	Expenses
(a)	Cost of materials consumed	263280000	1005250000
(b)	Purchases of stock-in-trade	30380000	127410000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-94560000	-72870000
(d)	Employee benefit expense	82380000	294830000
(e)	Finance costs	23350000	69460000
(f)	Depreciation, depletion and amortisation expense	57290000	223780000
(f)	Other Expenses
1	Labour/Service charges, Freight,Warehousing and Handling charges, Repairs & Maintenance etc.	114620000	272800000
2	Consumption of stores, spare & Packing material.	55510000	145600000
3	tPower and fuel	55460000	205520000
4	Legal and Professional Fees	57160000	164850000
5	others	119140000	516880000
	Total other expenses	401890000	1305650000
	Total expenses	764010000	2953510000
3	Total profit before exceptional items and tax	285850000	966530000
4	Exceptional items	-447310000	-447310000
5	Total profit before tax	-161460000	519220000
6	Tax expense
7	Current tax	-42930000	112530000
8	Deferred tax	13390000	25830000
9	Total tax expenses	-29540000	138360000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-131920000	380860000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-131920000	380860000
17	Other comprehensive income net of taxes	130000	-6890000
18	Total Comprehensive Income for the period	-131790000	373970000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	-133750000	367140000
	Total profit or loss, attributable to non-controlling interests	1960000	1960000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-133750000	367140000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	1960000	6830000
21	Details of equity share capital
	Paid-up equity share capital	71990000	71990000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		5311390000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-1.83	5.29
	Diluted earnings (loss) per share from continuing operations	-1.83	5.29
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-1.83	5.29
	Diluted earnings (loss) per share from continuing and discontinued operations	-1.83	5.29
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		NOTES n n1.The above financial results of Ganesh Benzoplast Limited were reviewed by the audit committee and approved by the Board of Directors at their respective meetings held on 14th May 2025. The statutory auditors of the Company have conducted the audit of the above Consolidated Financial Results for the quarter and year ended March 31, 2025. n n2.The above results of the Company have been prepared in accordance with the recognition and measurement principles and procedures laid down in Indian Accounting Standards 34 Interim Financial Reporting IND 34 prescribed under section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India. n n3. Pursuant to the Settlement Agreement dated January 17, 2025 the Company has successfully concluded its legal dispute with Morgan Securities and Credits Pvt. Ltd . Under the settlement terms the Company has paid one-time sum of Rs. 438.63 million as full and final resolution. This settlement removes significant operational constraints previously imposed on the Company enabling it to focus on core business activities and pursue accelerated growth opportunities. Importantly, the Company maintains a strong liquidity position ensuring no material impact on its financial stability while securing a clear path forward for strategic initiatives. The Company has recognized a one-time GST liability of Rs. 8.68 million under GST Audit of Chemical division for 5 years. This amount has been classified as an exceptional item in the financial statements, reflecting its non recurring nature. n n4. During the FY25 PAT without exceptional item is Rs. 723 million as compared to Rs. 614 million during FY24 with an increase of18% YOY. EPS before exceptional item for FY25 is Rs. 10 as compared to Rs. 8.5 in FY24 with an increase of 18% YOY. n n n5.The figures for the corresponding previous period have been regrouped / rearranged wherever necessary, to make them comparable.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	3263950000
	Capital work-in-progress	58320000
	Investment property	0
	Goodwill	224980000
	Other intangible assets	416260000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	156890000
	Trade receivables, non-current	0
	Loans, non-current	631350000
	Other non-current financial assets	174760000
	Total non-current financial assets	963000000
	Deferred tax assets (net)	0
	Other non-current assets	0
	Total non-current assets	4926510000
2	Current assets
	Inventories	261410000
	Current financial asset
	Current investments	36460000
	Trade receivables, current	584220000
	Cash and cash equivalents	90030000
	Bank balance other than cash and cash equivalents	897770000
	Loans, current	226390000
	Other current financial assets
	Total current financial assets	1834870000
	Current tax assets (net)	117790000
	Other current assets	94500000
	Total current assets	2308570000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	7235080000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	71990000
	Other equity	5311390000
	Total equity attributable to owners of parent	5383380000
	Non controlling interest	60650000
	Total equity	5444030000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	890000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	419660000
	Total non-current financial liabilities	420550000
	Provisions, non-current	68260000
	Deferred tax liabilities (net)	226570000
	Deferred government grants, Non-current	0
	Other non-current liabilities	22310000
	Total non-current liabilities	737690000
	Current liabilities
	Current financial liabilities
	Borrowings, current	192240000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	42660000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	362370000
	Total Trade payable	405030000
	Other current financial liabilities	367170000
	Total current financial liabilities	964440000
	Other current liabilities	68010000
	Provisions, current	20910000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	1053360000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	1791050000
	Total equity and liabilites	7235080000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	LST DIVISION (INCLUDING EPC, WHARFAGE AND RAIL LOGISTIC)	515050000	2004810000
2	CHEMICAL DIVISION	484290000	1738300000
	Total Segment Revenue	999340000	3743110000
	Less: Inter segment revenue	0	0
	Revenue from operations	999340000	3743110000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	LST DIVISION (INCLUDING EPC, WHARFAGE AND RAIL LOGISTIC)	239100000	819020000
2	CHEMICAL DIVISION	67740000	206340000
	Total Profit before tax	306840000	1025360000
	i. Finance cost	23350000	23350000
	ii. Other Unallocable Expenditure net off Unallocable income	-2360000	-2360000
	Profit before tax	285850000	966530000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	LST DIVISION (INCLUDING EPC, WHARFAGE AND RAIL LOGISTIC)	6527340000	6527340000
2	CHEMICAL DIVISION	596610000	596610000
	Total Segment Asset	7123950000	7123950000
	Un-allocable Assets	111130000	111130000
	Net Segment Asset	7235080000	7235080000
4	Segment Liabilities
	Segment Liabilities
1	LST DIVISION (INCLUDING EPC, WHARFAGE AND RAIL LOGISTIC)	1339000000	1339000000
2	CHEMICAL DIVISION	271620000	271620000
	Total Segment Liabilities	1610620000	1610620000
	Un-allocable Liabilities	180430000	180430000
	Net Segment Liabilities	1791050000	1791050000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclasssified to profit and loss	180000	-9200000
	Total Amount of items that will not be reclassified to profit and loss	180000	-9200000
2	Income tax relating to items that will not be reclassified to profit or loss	50000	-2310000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss
5	Total Other comprehensive income	130000	-6890000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			519220000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			69460000
	Adjustments for decrease (increase) in inventories			-62810000
	Adjustments for decrease (increase) in trade receivables, current			-12690000
	Adjustments for decrease (increase) in trade receivables, non-current			-42100000
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-118370000
	Adjustments for increase (decrease) in trade payables, non-current			192120000
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			223780000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			0
	Adjustments for interest income			66910000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			1850000
	Other adjustments for non-cash items			16920000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			201250000
	Net cash flows from (used in) operations			720470000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			171040000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			549430000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			-7390000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			390200000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			-325080000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			66910000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			39540000
	Net cash flows from (used in) investing activities	-601440000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			2500000
	Payments of lease liabilities			0
	Dividends paid			0
	Interest paid			69460000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			63170000
	Net cash flows from (used in) financing activities			-8790000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-60800000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-60800000
	Cash and cash equivalents cash flow statement at beginning of period			150830000
	Cash and cash equivalents cash flow statement at end of period			90030000